Skip to content

Clinical trials

Phase 3 Carcinoma, Hepatocellular trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Phase 3 Status: Unknown status Clear all

70 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20041
20061
20072
20091
20103
20112
20121
20134
20143
20153
20167
20176
20187
201911
20204
20213
20226
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status70

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sun Yat-sen University24
Guangxi Medical University10
Fudan University5
Shanghai Zhongshan Hospital5
Shenzhen Kangzhe Pharmaceutical Co., Ltd.2
Ain Shams University1
Chang Gung Memorial Hospital1
Chinese PLA General Hospital1
First Affiliated Hospital of Zhejiang University1
Gao-jun Teng1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular70
Liver Neoplasms9
Recurrence4
Fibrosis2
Hypertension, Portal2
Carcinoma1
Cholangiocarcinoma1
Hepatitis1
Hepatitis C, Chronic1
Hypoproteinemia1

Trials

Showing 1 to 25 of 70. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.